Sun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth was fueled by its branded businesses in India and emerging markets, along with global innovative medicines. The company also declared an interim dividend.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets